                                                                                                                                   II




                                  113TH CONGRESS
                                     1ST SESSION                            S. 136
                                     To amend the Internal Revenue Code of 1986 to provide a Federal income
                                              tax credit for certain stem cell research expenditures.




                                              IN THE SENATE OF THE UNITED STATES
                                                        JANUARY 24 (legislative day, JANUARY 3), 2013
                                    Mr. VITTER         introduced the following bill; which was read twice and referred
                                                                 to the Committee on Finance




                                                                            A BILL
                                  To amend the Internal Revenue Code of 1986 to provide
                                     a Federal income tax credit for certain stem cell research
                                     expenditures.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,
                                    3     SECTION 1. SHORT TITLE.
                                    4              This Act may be cited as the ‘‘Ethical Stem Cell Re-
                                    5 search Tax Credit Act of 2013’’.
                                    6     SEC. 2. CREDIT FOR ETHICAL STEM CELL RESEARCH.

                                    7              (a) IN GENERAL.—Subpart D of part IV of sub-
                                    8 chapter A of chapter 1 of the Internal Revenue Code of




                                    9 1986 is amended by adding at the end the following new
                                  10 section:

                                    1     ‘‘SEC. 45S. ETHICAL STEM CELL RESEARCH.        2
                                    2              ‘‘(a) ALLOWANCE                   OF      CREDIT.—For purposes of sec-
                                    3 tion 38, in the case of an eligible taxpayer, the ethical stem
                                    4 cell research credit determined under this section for the
                                    5 taxable year shall be an amount equal to 30 percent of
                                    6 the qualified stem cell research expenses paid or incurred
                                    7 by the taxpayer during the taxable year.
                                    8              ‘‘(b) ELIGIBLE TAXPAYER.—For purposes of this
                                    9 section, the term ‘eligible taxpayer’ means any taxpayer
                                  10 that elects the application of this section for the taxable
                                  11 year.
                                  12               ‘‘(c)       QUALIFIED                STEM             CELL         RESEARCH     EX-
                                  13      PENSES.—For                 purposes of this section—
                                  14                         ‘‘(1) IN        GENERAL.—The                     term ‘qualified stem
                                  15               cell research expenses’ means expenses which are
                                  16               paid or incurred by the eligible taxpayer during the
                                  17               taxable year in carrying on basic and applied re-
                                  18               search to develop techniques for the isolation, deriva-
                                  19               tion, production, testing, and human clinical use of
                                  20               stem cells that may result in improved under-
                                  21               standing of or treatments for diseases and other ad-
                                  22               verse health conditions, no part of which may in-
                                  23               volve—
                                  24                                  ‘‘(A) the creation of a human embryo for




                                  25                         research purposes,
                                              •S 136 IS

                                                                                             3
                                    1                                 ‘‘(B) the destruction of or discarding of, or
                                    2                        risk of injury to, a human embryo, or
                                    3                                 ‘‘(C) the use of any stem cell, the deriva-
                                    4                        tion or provision of which would be inconsistent
                                    5                        with subparagraph (A) or (B).
                                    6                        ‘‘(2) HUMAN              EMBRYO.—The                    term ‘human em-
                                    7              bryo’ means any organism not protected as a human
                                    8              subject under part 46 of title 45, Code of Federal
                                    9              Regulations (as in effect on the date of the enact-
                                  10               ment of this section) that is derived by fertilization,
                                  11               parthenogenesis, cloning, or any other means from
                                  12               one or more human gametes or human diploid cells.
                                  13                         ‘‘(3) RISK           OF INJURY.—The                      term ‘risk of in-
                                  14               jury’ means subjecting a human embryo to risk of
                                  15               injury or death greater than that allowed for re-
                                  16               search on a fetus in utero under section 498(b) of
                                  17               the Public Health Service Act (42 U.S.C. 289g(b))
                                  18               (as in effect on the date of the enactment of this
                                  19               section) and section 46.204(b) of title 45, Code of
                                  20               Federal Regulations (as so in effect).
                                  21               ‘‘(d) TREATMENT                    OF         QUALIFIED STEM CELL RE-
                                  22      SEARCH           EXPENSES.—
                                  23                         ‘‘(1) IN      GENERAL.—Except                       as provided in para-
                                  24               graph (2), any qualified stem cell research expenses




                                  25               for a taxable year to which an election under this
                                              •S 136 IS

                                                                                             4
                                    1              section applies shall not be taken into account for
                                    2              purposes of determining the credit allowable under
                                    3              section 41 for such taxable year.
                                    4                        ‘‘(2) TREATED               AS BASE PERIOD RESEARCH EX-
                                    5              PENSES.—Any                    qualified stem cell research expenses
                                    6              for any taxable year which are qualified research ex-
                                    7              penses (within the meaning of section 41(b)) shall be
                                    8              taken into account in determining base period re-
                                    9              search expenses for purposes of applying section 41
                                  10               to subsequent taxable years.
                                  11               ‘‘(e) SPECIAL RULES.—
                                  12                         ‘‘(1) LIMITATION.—No credit shall be allowed
                                  13               under this section with respect to any stem cell re-
                                  14               search conducted by a corporation to which an elec-
                                  15               tion under section 936 applies.
                                  16                         ‘‘(2) AGGREGATION                    OF EXPENDITURES AND AL-
                                  17               LOCATIONS OF CREDIT.—Rules                                    similar to the rules
                                  18               of paragraphs (1) and (2) of section 41(f) and sec-
                                  19               tion 41(g) shall apply for purposes of this section.’’.
                                  20               (b) CREDIT ALLOWED                            AS   PART       OF    GENERAL BUSI-
                                  21      NESS        CREDIT.—Section 38(b) of the Internal Revenue
                                  22 Code of 1986 is amended by striking ‘‘plus’’ at the end
                                  23 of paragraph (35), by striking the period at the end of
                                  24 paragraph (36) and inserting ‘‘, plus’’, and by adding at




                                  25 the end the following new paragraph:
                                              •S 136 IS

                                                                                             5
                                    1                        ‘‘(37) the ethical stem cell research credit deter-
                                    2              mined under section 45S(a).’’.
                                    3              (c) DENIAL OF DOUBLE BENEFIT.—
                                    4                        (1) TECHNICAL                   AMENDMENT.—The                        second sub-
                                    5              section (g) of section 280C of the Internal Revenue
                                    6              Code of 1986, as added by section 1401(b) of the
                                    7              Patient Protection and Affordable Care Act, is re-
                                    8              designated as subsection (i).
                                    9                        (2) IN      GENERAL.—Section                      280C of the Internal
                                  10               Revenue Code of 1986, as amended by paragraph
                                  11               (1), is further amended by adding at the end the fol-
                                  12               lowing new subsection:
                                  13               ‘‘(j) ETHICAL STEM CELL RESEARCH CREDIT.—
                                  14                         ‘‘(1) IN        GENERAL.—No                    deduction shall be al-
                                  15               lowed for that portion of the qualified stem cell re-
                                  16               search expenses (as defined in section 45S(c)(1))
                                  17               otherwise allowable as a deduction for the taxable
                                  18               year which is equal to the amount of the credit de-
                                  19               termined for such taxable year under section 45S(a).
                                  20                         ‘‘(2) SIMILAR               RULE WHERE TAXPAYER CAP-
                                  21               ITALIZES RATHER THAN DEDUCTS EXPENSES.—If—
                                  22                                  ‘‘(A) the amount of the credit determined
                                  23                         for the taxable year under section 45S(a), ex-
                                  24                         ceeds





                                              •S 136 IS

                                                                                             6
                                    1                                 ‘‘(B) the amount allowable as a deduction
                                    2                        for such taxable year for qualified stem cell re-
                                    3                        search expenses (determined without regard to
                                    4                        paragraph (1)),
                                    5              the amount chargeable to capital account for the
                                    6              taxable year for such expenses shall be reduced by
                                    7              the amount of such excess.
                                    8                        ‘‘(3) CONTROLLED                    GROUPS.—Paragraph                 (3) of
                                    9              subsection (b) shall apply for purposes of this sub-
                                  10               section.’’.
                                  11               (d) CLERICAL AMENDMENT.—The table of sections
                                  12 for subpart D of part IV of subchapter A of chapter 1
                                  13 of the Internal Revenue Code of 1986 is amended by add-
                                  14 ing at the end the following new item:
                                          ‘‘Sec. 45S. Ethical stem cell research.’’.

                                  15               (e) EFFECTIVE DATE.—The amendments made by
                                  16 this section shall apply to amounts paid or incurred after
                                  17 the date of the enactment of this Act.
                                              •S 136 IS                                    Æ
